EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS023-15612 
Organism
Homo sapiens 
Tissue/cell
CD8+ 
Coordinate
chr2:235231270-235232640 
TF binding sites/motifs
Number: 7             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
ELF1MA0473.2chr2:235232532-235232544CACTTCCGGTTT-6.27
ELF4MA0641.1chr2:235232532-235232544CACTTCCGGTTT-6.27
ELK1MA0028.2chr2:235232532-235232542CACTTCCGGT-6.02
ERGMA0474.2chr2:235232532-235232542CACTTCCGGT-6.02
ETS1MA0098.3chr2:235232532-235232542CACTTCCGGT-6.02
FEVMA0156.2chr2:235232532-235232542CACTTCCGGT-6.02
FLI1MA0475.2chr2:235232532-235232542CACTTCCGGT-6.02
Number of super-enhancer constituents: 1             
IDCoordinateTissue/cell
SE_17518chr2:235230984-235233139CD4p_CD25-_CD45RAp_Naive
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr2235231865235232186
Number: 1             
IDChromosomeStartEnd
GH02I234323chr2235231865235232186
Enhancer Sequence
GATTTGCTTT AAAATTTTTT AAAATGTAGA CTAGGGCAAT GTGAGACAAG ATTTTTTAAA 60
TGGTGATAAT CATTGAAGCT GAAACGGGTA ATGGGCACAT TGATGTATTA TAGTTTTTAA 120
TTTTGGGGTA TGTTTGAAAT TTTCTGAAAA AGAAAAAAGT AATAATACAA CTGGCTGCAG 180
TTATGAAAAT AAAAGTAAAT CAATATCAGG ATAATCTTGG GTCTCAGTGT GTTAATTCAG 240
GATAATTCAA GATTTTACTG ACACTGAAAC ATTAGATTTA GTGGATTCTT TTTCTCTGTC 300
AACATTACTG TTCGTGATGT TGTTTCATGC GTCAGATGCT AGGGACATAT TTTCAGTGTT 360
TATACTGGGA AATGCTAAAA TTTTCTTGAC TTCCTTTTTA TGAATCAAGT TGTTTATCAC 420
TAATTGCTCT TTAACTGCCT GTTCAATACA TTAAGATCAA GAATCTCTAA CTCCTATTTA 480
ATTCTAAAGG AATTTTCAGT GATATAAGAA ATAAAGAAGC ATAGGAGGAT TAAAGACTTA 540
AAAATTCAGA GATTATGCAA AATGAACAAA GAAAGCTCAC ATTTCCAGGT AGCACTGAGA 600
AAGTGTCTTG GAAACAGGAT ACCATATTTG TTTCTGAGTT TCCTGGTAAC CAAGGCTAAA 660
AGCAAAACAC AGATGATACC CAGAAAGTAA AATCAGACAC ATTAACCTGC ATTCATAATA 720
AAACTACACT TCTGATGAAA TACATCTCTA ATGATTATTC TTGGATATGG AGTAGCACTA 780
ATATCACCTT CACTTGCTGT TTTATATAAG ACATAGGGAT GCCATGTAAA TAAAAGCTTA 840
CCGAATTCAT TCTCTATGAA GCTTAAAAAT ACATTGTTAA TTATAAATCA GTAGCATTGG 900
CTCCATGGAA AGTTAAAAAA ATATGGTCCA GGCATTTTGT TTTCTGAAGA TCTAAGTAAA 960
GTGAATAATA TCAAAGAATG GTCAAGCCAT GTGTCCTTAG TTAGTCTGTC TGGCACCTCC 1020
AGGATTTGGT GAAACCTGGG CAGGGGCTGG AGAAGCAGAG TTGCCCTCTC TCCCAGACTC 1080
TCTTATGCCC ACACTGACCA TTGATCCCCC CACTGTACTT TGGGAAGACA CCAATTCTGT 1140
TAGACCTTCC CAGGGACCTT ACCAAAAAGG TTTCAAAGTC AAGTACTGAG ATGTGATGGT 1200
CTGAACAGTG TTACACCAGT TTTCTTTTTC TTTTTCTTTT TTCTTATTTT TTTGCTGCAG 1260
GACACTTCCG GTTTTGAACA CACCAGGTTT TAATTTGAAT GTGTGAGAGG CGTAGAGTGT 1320
ACGATTTCTC CAGTTTGGTT GACCACGGAA TCCCTCTTTC TCCCCTGCTT 1370